US Stock MarketDetailed Quotes
SGMT Sagimet Biosciences
- 4.310
- +0.170+4.11%
Close Oct 11 16:00 ET
- 4.420
- +0.110+2.55%
Post 20:01 ET
138.76MMarket Cap-4700P/E (TTM)
4.420High4.030Low681.34KVolume4.030Open4.140Pre Close2.92MTurnover4.13%Turnover RatioLossP/E (Static)32.20MShares20.71052wk High0.76P/B71.03MFloat Cap2.13052wk Low--Dividend TTM16.48MShs Float20.710Historical High--Div YieldTTM9.42%Amplitude2.130Historical Low4.286Avg Price1Lot Size
Sagimet Biosciences Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 2M | 0 | 2M | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --2M | --0 | --2M | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 50.05%10.59M | 29.61%8.77M | 5.43%32.74M | 28.13%9.47M | 22.98%9.45M | -2.50%7.06M | -22.62%6.77M | 30.93%31.06M | 7.39M | 7.69M |
| Selling and administrative expenses | 79.59%4.28M | 53.91%3.51M | 111.26%12.96M | 147.24%3.81M | 429.95%4.49M | 174.63%2.38M | -20.90%2.28M | 40.12%6.14M | --1.54M | --848K |
| -General and administrative expense | 79.59%4.28M | 53.91%3.51M | 111.26%12.96M | 147.24%3.81M | 429.95%4.49M | 174.63%2.38M | -20.90%2.28M | 40.12%6.14M | --1.54M | --848K |
| Research and development costs | 35.01%6.31M | 17.27%5.26M | -20.63%19.78M | -3.27%5.66M | -27.49%4.96M | -26.60%4.68M | -23.47%4.49M | 28.85%24.92M | --5.85M | --6.84M |
| Operating profit | -50.05%-10.59M | -29.61%-8.77M | 1.01%-30.74M | -28.13%-9.47M | 3.04%-7.45M | 2.50%-7.06M | 22.62%-6.77M | -30.93%-31.06M | -7.39M | -7.69M |
| Net non-operating interest income expense | 808.46%2.47M | 1,088.33%2.14M | 417.18%2.86M | 580.83%1.31M | 402.29%1.1M | 100.00%272K | 2,900.00%180K | 2,026.92%553K | 193K | 218K |
| Non-operating interest income | 808.46%2.47M | 1,088.33%2.14M | 417.18%2.86M | 580.83%1.31M | 402.29%1.1M | 100.00%272K | 2,900.00%180K | 2,026.92%553K | --193K | --218K |
| Other net income (expense) | 33.33%4K | 1K | 300.00%4K | -200.00%-2K | 100.40%3K | 0 | 1K | |||
| Gain on sale of security | ---- | ---- | 33.33%4K | --1K | 300.00%4K | ---- | -200.00%-2K | 100.40%3K | --0 | --1K |
| Income before tax | -19.65%-8.12M | -0.64%-6.63M | 8.60%-27.88M | -13.29%-8.15M | 14.92%-6.35M | 4.46%-6.79M | 24.59%-6.59M | -24.78%-30.5M | -7.2M | -7.47M |
| Income tax | ||||||||||
| Net income | -19.65%-8.12M | -0.64%-6.63M | 8.60%-27.88M | -13.29%-8.15M | 14.92%-6.35M | 4.46%-6.79M | 24.59%-6.59M | -24.78%-30.5M | -7.2M | -7.47M |
| Net income continuous Operations | -19.65%-8.12M | -0.64%-6.63M | 8.60%-27.88M | -13.29%-8.15M | 14.92%-6.35M | 4.46%-6.79M | 24.59%-6.59M | -24.78%-30.5M | ---7.2M | ---7.47M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -19.65%-8.12M | -0.64%-6.63M | 8.60%-27.88M | -13.29%-8.15M | 14.92%-6.35M | 4.46%-6.79M | 24.59%-6.59M | -24.78%-30.5M | -7.2M | -7.47M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -19.65%-8.12M | -0.64%-6.63M | 8.60%-27.88M | -13.29%-8.15M | 14.92%-6.35M | 4.46%-6.79M | 24.59%-6.59M | -24.78%-30.5M | -7.2M | -7.47M |
| Basic earnings per share | 18.30%-0.25 | 22.57%-0.23 | -93.39%-2.66 | -9.72%-0.356 | -3.94%-0.35 | 4.46%-0.306 | 24.59%-0.2971 | -24.78%-1.3754 | -0.3245 | -0.3367 |
| Diluted earnings per share | 18.30%-0.25 | 22.57%-0.23 | -93.39%-2.66 | -9.72%-0.356 | -3.94%-0.35 | 4.46%-0.306 | 24.59%-0.2971 | -24.78%-1.3754 | -0.3245 | -0.3367 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data